American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics | October 20, 2017

October 20, 2017 — The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave...

Trial Data Shows Positive Predictive Results for Boston Scientific HeartLogic Heart Failure Diagnostic
News | Heart Failure | October 20, 2017

October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart...

Cardiovascular Risk Significantly Higher in Women With Fatty Liver Disease
News | Womens Healthcare | October 20, 2017

October 20, 2017 — Nonalcoholic fatty liver disease (NAFLD) is associated with significantly higher risk of...

Analytics 4 Life Raises $25 Million for AI-Backed Cardiac Imaging Technology
News | Advanced Visualization | October 20, 2017

October 20, 2017 — Digital health company Analytics 4 Life announced it has completed a $25 million Series B...

Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement | October 19, 2017

October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare...

Endologix Receives IDE Approval for EVAS2 Confirmatory Clinical Study
News | Endovascular Aortic Repair | October 19, 2017

October 19, 2017 — Endologix Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and...

The Role of Telomere Length in Cardiovascular Risk Assessment
Feature | Cardiac Diagnostics | October 19, 2017 | Nanette H. Bishopric, M.D., FACC, FAHA

A new area of DNA testing involving telomere length may enhance a patient’s cardiovascular disease risk...

The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure | October 18, 2017

October 18, 2017 — The U.S. Food and Drug Administration (FDA) recently approved a new treatment option for patients...

MRI May Predict Neurological Outcomes for Cardiac Arrest Survivors
News | Sudden Cardiac Arrest | October 18, 2017

October 18, 2017 — Magnetic resonance imaging (MRI)-based measurements of the functional connections in the brain...

Xarelto Significantly Reduces Major Cardioavascular Events in Stable CAD and PAD Patients
News | Pharmaceuticals | October 18, 2017

October 18, 2017 — Results from the pivotal Phase 3 COMPASS study found that the...

Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab | October 18, 2017

October 18, 2017 — Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training...

Societies Issue New Performance and Quality Measures for Treating Patients with Heart Attack
News | Cath Lab | October 17, 2017

October 17, 2017 — The American College of Cardiology and the American Heart Association recently released updated...

First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure | October 17, 2017

October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S. arm of the ALIVE...

Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support | October 16, 2017

October 16, 2017 — The American College of Cardiology (ACC), along with several partnering societies, recently...

Overlay Init